Fig. 10

The potential mechanisms of TMED2-mediated inflammation regulation in LUAD. TMED2 may regulate inflammation via the TLR4/NF-κB signaling pathway, decreasing the levels of inflammatory factors in tumor cell and then increasing their pathological mitosis